As expected, quantification of tumor-infiltrating immune cells revealed that FATS deficiency significantly reduced the fractions of total myeloid cells (CD11b+) and TAMs (Ly6G−CD11b+F4/80+) but did not alter the fractions of monocytes (Ly6G-CD11b+Ly6Chi) and granulocytes (CD11b+Ly6G+) (Fig. 2a) as determined using the gating strategy shown in Supplementary Fig. 1a. Here, ITGAM is linked to neoplasm.